Carlo Torti

Magna Graecia University of Catanzaro - Department of Medical and Surgical Sciences

SCHOLARLY PAPERS

2

DOWNLOADS

180

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Real-Life Comparison of Mortality in Non-Hospitalised Patients with SARS-CoV-2 Infection at Risk for Clinical Progression Treated with Molnupiravir or Nirmatrevir Plus Ritonavir During the Omicron Era in Italy: A Nationwide, Observational Study

Number of pages: 35 Posted: 10 May 2023
Magna Graecia University of Catanzaro - Department of Medical and Surgical Sciences, The Italian Medicines Agency (AIFA), University of Milano-Bicocca - Fondazione IRCCS San Gerardo dei Tintori, Udine University Hospital - Department of Medicine (DAME), Infectious Diseases Clinic, The Italian Medicines Agency (AIFA), San Donato Hospital - Department of Specialised and Internal Medicine, Infectious Diseases Unit, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, University of Verona - Infectious Diseases, Department of Diagnostic and Public Health, University of Catania School of Medicine - Department of Internal and Experimental Medicine, D. Cotugno Hospital - Division Emerging Infectious Disease and High Contagiousness, San Giuseppe Moscati Hospital - Infectious Diseases Unit, Pescara General Hospital - Department of Medicine, Infectious Disease Unit, University of Genoa - Department of Health Sciences (DISSAL), Infermi Hospital, AUSL Romagna - Unit of Infectious Disease, Azienda Ospedaliera Universitaria - Ospedali Riuniti di Ancona, Central Hospital of Bolzano - Department of Infectious Disease, A.O.R. San Carlo - Infectious Diseases Unit, Santa Chiara Hospital - Infectious Diseases Unit, Department of Medical, The Italian Medicines Agency (AIFA), Sapienza University of Rome - Department of Public Health and Infectious Diseases, Sapienza University of Rome - Department of Public Health and Infectious Diseases, University of Torino - Unit of Infectious Diseases, Italian Medicines Agency and The Italian Medicines Agency (AIFA)
Downloads 123 (468,964)

Abstract:

Loading...

COVID-19, SARS-CoV-2, nirmatrelvir/ritonavir, molnupiravir, real-world, effectiveness

2.

Comparative Analysis of Early COVID-19 Treatment Efficacy in a Multicentric Regional Cohort in Italy: Emulation of a Series of Target Trials

TLRHEUROPE-D-24-00554, https://doi.org/10.2139/ssrn.4901222
Number of pages: 19 Posted: 07 Aug 2024
Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, University College London - Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Sapienza University of Rome, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Clinical Division of Infectious Diseases, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Sapienza University of Rome, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Catholic University of Milan, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Clinical Department, University of Rome Tor Vergata, Sapienza University of Rome, Sapienza University of Rome, University of Udine, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Università Cattolica del Sacro Cuore, Sapienza University of Rome, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Laboratory of Virology, National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Sapienza University of Rome, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Translational Research Unit, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, University of Rome Tor Vergata, Sapienza University of Rome - Department of Public Health and Infectious Diseases, University of Rome Tor Vergata - Faculty of Medicine and Surgery, Magna Graecia University of Catanzaro - Department of Medical and Surgical Sciences, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Laboratory of Virology, Sapienza University of Rome, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Clinical Department and Independent
Downloads 57 (743,875)

Abstract:

Loading...

COVID-19, early treatment, outpatients, fragile populations